CU22774A3 - Nueva variante cristalina del cdch, procedimiento para su producción y preparados farmacéuticos que la contienen - Google Patents

Nueva variante cristalina del cdch, procedimiento para su producción y preparados farmacéuticos que la contienen

Info

Publication number
CU22774A3
CU22774A3 CU1996111A CU1996111A CU22774A3 CU 22774 A3 CU22774 A3 CU 22774A3 CU 1996111 A CU1996111 A CU 1996111A CU 1996111 A CU1996111 A CU 1996111A CU 22774 A3 CU22774 A3 CU 22774A3
Authority
CU
Cuba
Prior art keywords
cdch
production
pharmaceutical preparations
variante
procedure
Prior art date
Application number
CU1996111A
Other languages
English (en)
Spanish (es)
Inventor
Alfons Grunenberg
Patrick Bosche
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7779831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU22774(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CU22774A3 publication Critical patent/CU22774A3/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CU1996111A 1995-12-12 1996-11-27 Nueva variante cristalina del cdch, procedimiento para su producción y preparados farmacéuticos que la contienen CU22774A3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19546249A DE19546249A1 (de) 1995-12-12 1995-12-12 Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
CU22774A3 true CU22774A3 (es) 2002-07-24

Family

ID=7779831

Family Applications (1)

Application Number Title Priority Date Filing Date
CU1996111A CU22774A3 (es) 1995-12-12 1996-11-27 Nueva variante cristalina del cdch, procedimiento para su producción y preparados farmacéuticos que la contienen

Country Status (42)

Country Link
US (1) US5849752A (enEXAMPLES)
EP (1) EP0780390B1 (enEXAMPLES)
JP (1) JP4104687B2 (enEXAMPLES)
KR (1) KR100525146B1 (enEXAMPLES)
CN (1) CN1061348C (enEXAMPLES)
AR (1) AR005009A1 (enEXAMPLES)
AT (1) ATE221531T1 (enEXAMPLES)
AU (1) AU708006B2 (enEXAMPLES)
BG (1) BG62258B1 (enEXAMPLES)
BR (1) BR9605968A (enEXAMPLES)
CA (1) CA2192418C (enEXAMPLES)
CO (1) CO4480105A1 (enEXAMPLES)
CU (1) CU22774A3 (enEXAMPLES)
CZ (1) CZ288657B6 (enEXAMPLES)
DE (2) DE19546249A1 (enEXAMPLES)
DK (1) DK0780390T3 (enEXAMPLES)
EE (1) EE03474B1 (enEXAMPLES)
ES (1) ES2179910T3 (enEXAMPLES)
HR (1) HRP960558B1 (enEXAMPLES)
HU (1) HU226521B1 (enEXAMPLES)
ID (1) ID22625A (enEXAMPLES)
IL (1) IL119795A (enEXAMPLES)
IN (1) IN185805B (enEXAMPLES)
MA (1) MA24342A1 (enEXAMPLES)
MY (1) MY117492A (enEXAMPLES)
NL (1) NL300109I1 (enEXAMPLES)
NO (1) NO306725B1 (enEXAMPLES)
NZ (1) NZ299905A (enEXAMPLES)
PL (1) PL184885B1 (enEXAMPLES)
PT (1) PT780390E (enEXAMPLES)
RO (1) RO119782B1 (enEXAMPLES)
RU (1) RU2162468C2 (enEXAMPLES)
SA (1) SA96170492B1 (enEXAMPLES)
SG (1) SG47201A1 (enEXAMPLES)
SI (1) SI0780390T1 (enEXAMPLES)
SK (1) SK282805B6 (enEXAMPLES)
SV (1) SV1996000109A (enEXAMPLES)
TR (1) TR199600970A2 (enEXAMPLES)
TW (1) TW411340B (enEXAMPLES)
UA (1) UA35638C2 (enEXAMPLES)
YU (1) YU49485B (enEXAMPLES)
ZA (1) ZA9610405B (enEXAMPLES)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU731693B2 (en) * 1997-09-25 2001-04-05 Bayer Intellectual Property Gmbh Drug formulation having controlled release of active compound
DE19751948A1 (de) 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
HK1042245B (zh) * 1998-11-10 2005-03-11 Bayer Intellectual Property Gmbh 莫西沙星药物制剂
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854356A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
WO2004039804A1 (en) * 2002-10-31 2004-05-13 Ranbaxy Laboratories Limited Amorphous moxifloxacin hydrochloride
ATE439840T1 (de) 2003-04-09 2009-09-15 Reddys Lab Ltd Dr Kristalline form iii von wasserfreiem moxifloxacin-hydrochlorid und ein verfahren zu seiner herstellung
US20060264635A1 (en) * 2003-08-05 2006-11-23 Chava Satyanarayana Process for the preparation of moxifloxacin hydrochloride
ITMI20032259A1 (it) 2003-11-20 2005-05-21 Chemi Spa Nuovo polimorfo dell'acido 1-ciclopropil-7-(s,s-2,8-diazabciclo-4.3.0-non-8-il)-6-fluoro-1,4-diidro-8-metossi-4-oxo-chinolin carbossilico cloridrato e metodi per la sua preparazione
ES2319125T3 (es) * 2003-11-20 2009-05-04 Chemi S.P.A. Polimorfos del clorhidrato del acido 1-ciclopropil-7-((s,s)-2,8-diazadiciclo(4.3.0)-non-8-il)-6-fluoro-1,4-dihidro-8-metoxi-4-oxo-3-quinolina carboxilico y metodos para la preparacion de los mismos.
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
DE102004015981A1 (de) * 2004-04-01 2005-10-20 Bayer Healthcare Ag Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE102004063347A1 (de) * 2004-12-23 2006-07-13 Stada Arzneimittel Ag Gebrauchsfertige Gemcitabinlösungen und Gemcitabinlösungskonzentrate
WO2007033515A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation orale contenant de la moxifloxacine et son procédé de préparation
GB0612422D0 (en) * 2006-06-23 2006-08-02 Generics Uk Ltd Novel hydrate form
SI2032521T1 (sl) 2006-06-27 2010-02-26 Sandoz Ag Nov postopek za pripravo soli
ES2303768B1 (es) * 2006-09-08 2009-06-05 Quimica Sintetica, S.A. Nueva forma cristalina de moxifloxacino clorhidrato.
EP2474547A3 (en) * 2006-11-13 2012-07-25 Cipla Limited Process for the Synthesis of Moxifloxacin Hydrochloride
EP1992626A1 (en) * 2007-05-10 2008-11-19 Sandoz AG Process for the preparation of moxifloxacin hydrochloride
EP2083010A1 (en) * 2008-01-08 2009-07-29 Chemo Ibérica, S.A. Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof
EP2154137A1 (en) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Crystalline form of moxifloxacin base
BRPI0823092A2 (pt) * 2008-10-09 2015-09-29 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi método de granulação úmida de moxifloxacin anídrico ou seus sais
EP2342204A1 (en) * 2008-11-06 2011-07-13 Hetero Research Foundation Novel polymorph of moxifloxacin hydrochloride
EA028676B1 (ru) 2008-12-08 2017-12-29 Рациофарм Гмбх Спрессованный моксифлоксацин
NZ610978A (en) 2009-05-15 2014-11-28 Redx Pharma Ltd Redox drug derivatives
WO2011121596A2 (en) * 2010-04-01 2011-10-06 Neuland Laboratories Ltd. Crystal modification of moxifloxacin hydrochloride
BRPI1106900A2 (pt) 2011-12-26 2013-11-05 Ems Sa Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN102924449B (zh) * 2012-10-30 2015-08-12 重庆福安药业集团庆余堂制药有限公司 盐酸莫西沙星h晶型及其制备方法和药物组合物
WO2014087292A1 (en) 2012-12-04 2014-06-12 Mankind Research Centre An improved process for the preparation of moxifloxacin hydrochloride
RU2561037C2 (ru) * 2013-02-07 2015-08-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Антибактериальная фармацевтическая композиция и способ ее получения
MX388561B (es) 2013-03-15 2025-03-11 Melinta Subsidiary Corp Metodos para tratar infecciones en pacientes obesos y con sobrepeso usando antibioticos.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
AU618235B2 (en) * 1986-03-31 1991-12-19 Sankyo Company Limited Quinoline-3-carboxylic acid derivatives, their preparation and use
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
RO108347B1 (ro) * 1989-10-30 1994-04-28 Bellon Labor Sa Roger DERIVATI DE BENZO-(b)-NAFTIRIDIN-1,8 SI PROCEDEU DE PREPARARE A ACESTORA
TW209865B (enEXAMPLES) 1992-01-10 1993-07-21 Bayer Ag
ES2167329T3 (es) * 1992-01-31 2002-05-16 Chugai Pharmaceutical Co Ltd Cristal de hidrato de derivado de acido quinolonacarboxilico.
DE4234078A1 (de) 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
CA2112165C (en) * 1992-12-25 2003-04-08 Makoto Takemura Bicyclic amine derivatives
ZA946853B (en) * 1993-09-10 1995-04-24 Daiichi Seiyaku Co Crystals of antimicrobial compound.
DE69504392T2 (de) * 1994-04-07 1999-02-11 Pfizer Inc., New York, N.Y. Verwendung von Trovafloxacin oder dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung von H.Pylori Infektionen

Also Published As

Publication number Publication date
JPH09169757A (ja) 1997-06-30
MX9606325A (es) 1997-10-31
CZ364696A3 (en) 1997-07-16
HUP9603428A3 (en) 1997-10-28
CA2192418A1 (en) 1997-06-13
HUP9603428A2 (en) 1997-08-28
KR970042550A (ko) 1997-07-24
RU2162468C2 (ru) 2001-01-27
NO965298L (no) 1997-06-13
KR100525146B1 (ko) 2006-01-27
SI0780390T1 (en) 2002-10-31
NO306725B1 (no) 1999-12-13
HU9603428D0 (en) 1997-01-28
PL317415A1 (en) 1997-06-23
HU226521B1 (en) 2009-03-30
EP0780390B1 (de) 2002-07-31
SA96170492B1 (ar) 2006-05-23
CZ288657B6 (cs) 2001-08-15
SK282805B6 (sk) 2002-12-03
PL184885B1 (pl) 2003-01-31
BR9605968A (pt) 1998-08-18
AU7421696A (en) 1997-06-19
CN1061348C (zh) 2001-01-31
CN1160052A (zh) 1997-09-24
DK0780390T3 (da) 2002-11-11
TW411340B (en) 2000-11-11
UA35638C2 (uk) 2001-04-16
AR005009A1 (es) 1999-04-07
US5849752A (en) 1998-12-15
EP0780390A1 (de) 1997-06-25
RO119782B1 (ro) 2005-03-30
ZA9610405B (en) 1997-06-23
JP4104687B2 (ja) 2008-06-18
SV1996000109A (es) 1997-10-23
NZ299905A (en) 1998-09-24
YU49485B (sh) 2006-08-17
IL119795A0 (en) 1997-03-18
NO965298D0 (no) 1996-12-11
IL119795A (en) 1998-12-27
EE9600201A (et) 1997-06-16
CA2192418C (en) 2001-06-12
TR199600970A2 (tr) 1997-06-21
PT780390E (pt) 2002-11-29
BG101043A (en) 1998-04-30
ID22625A (id) 1999-12-02
CO4480105A1 (es) 1997-07-09
NL300109I1 (nl) 2003-02-03
EE03474B1 (et) 2001-08-15
AU708006B2 (en) 1999-07-29
DE59609501D1 (de) 2002-09-05
ATE221531T1 (de) 2002-08-15
MY117492A (en) 2004-07-31
IN185805B (enEXAMPLES) 2001-05-05
ES2179910T3 (es) 2003-02-01
MA24342A1 (fr) 1998-07-01
DE19546249A1 (de) 1997-06-19
BG62258B1 (bg) 1999-06-30
SG47201A1 (en) 1998-03-20
SK159196A3 (en) 1997-10-08
YU65096A (sh) 1998-12-23
HRP960558B1 (en) 2002-04-30
HRP960558A2 (en) 1998-02-28

Similar Documents

Publication Publication Date Title
CU22774A3 (es) Nueva variante cristalina del cdch, procedimiento para su producción y preparados farmacéuticos que la contienen
GB2303629B (en) Hydroxamic acids and their use as metalloproteinase inhibitors
UA29450C2 (uk) Похідні гідроксамової кислоти, спосіб їх одержання, спосіб впливу на хвороби та фармацевтична або ветеринарна композиція, що їх містить
ECSP055738A (es) PROCESO ENANTIOSELECTIVO PARA LA PREPARACIÓN DE AMBOS ENANTIÓMEROS DE 10,11-DIHIDRO-10-HIDROXI-5H-DIBENZ-[b,f]-AZEPIN-5-CARBOXAMIDA Y SUS NUEVAS FORMAS DE CRISTAL
EE03292B1 (et) Prootonpumba inhibiitorit sisaldav paljuosaline ravimpreparaat ja selle valmistamise protsess
EE200000318A (et) Uudsed ühendid
AR030541A1 (es) Acidos aminopropilfosfinicos, su utilizacion para la manufactura de medicamentos, y formulacion farmaceutica
HUT51269A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
SI1546127T1 (sl) Novi pirimidinamidni derivati in njihova uporaba
IT1265101B1 (it) Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
HUT54988A (en) Process for producing substituted n-(quinolin-2-ylmethoxy)-benzylsulfonylureas and pharmaceutical compositions comprising such compounds
NO172537C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-desmetyl-4-fluor-mevalonsyrederivater
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
ES2187030T3 (es) Una nueva sal.
AU2002224847A1 (en) N-alkylated gaba compounds, processes for their preparation and their use as medicaments
DE59010302D1 (de) R-(-)-1-(5-Hydroxyhexyl)-3-methyl-7-propylxanthin, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
ECSP961966A (es) Nueva variante cristalina del cdch. procedimiento para su produccion y preparados farmaceuticos que la contienen
DE69804766D1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
UA32583C2 (uk) Похідні арилтіоалкілтіопіридину
SG153894G (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
ZA824649B (en) New optically active dipeptides, process for their preparation and pharmaceutical products containing these compounds
DE60237994D1 (de) 3.beta.,28-diacetoxy-18-oxo-19,20,21,29,30-pentanorlupan-22-säure solvate, verfahren zu ihrer herstellung und pharmazeutische präparate daraus
AU2506188A (en) Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance
IT1254471B (it) Derivati ammidici della (r)-glicerofosforil-(s)-serina o del suo diacil derivato, un processo per la loro preparazione e relative composizioni farmaceutiche per il potenziamento dei processi di apprendimento
AU2003227008A1 (en) 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases

Legal Events

Date Code Title Description
MK Ceased due to expiration of term